Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Enge Biotech is a synthetic biology company based in Shanghai, China, specializing in the development and green manufacturing of high-value ingredients for the pharmaceutical, nutraceutical, and cosmetic industries. As a subsidiary of the Yunnan Energie group, the company leverages advanced biocatalysis and metabolic engineering to produce complex molecules such as Nicotinamide Mononucleotide (NMN), Glutathione, and Human Milk Oligosaccharides (HMOs). Enge Biotech's proprietary platform integrates enzyme directed evolution and high-throughput screening to replace traditional chemical synthesis with sustainable enzymatic processes. The company provides both a portfolio of catalog products and custom CDMO services for process development and large-scale bio-manufacturing. By focusing on efficiency and purity, Enge Biotech serves a global market seeking high-quality bio-based intermediates and health supplements.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Enge Biotech.